Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.28), $0.10 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $14.7 million versus the consensus estimate of $14.85 million.

GUIDANCE:

Apyx Medical Corp. sees FY2024 revenue of $49.7-52.9 million, versus the consensus of $60.18 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.